Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy

BACKGROUND: The National Comprehensive Cancer Network and American Society of Clinical Oncology recommend consideration of the use of echocardiography 6-12 months after completion of anthracycline-based chemotherapy in at risk populations. Assessment of brain natriuretic peptide (BNP) has also been...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Cardiovasc Qual Outcomes
Autors principals: Ruddy, Kathryn J., Sangaralingham, Lindsey R., Van Houten, Holly, Nowsheen, Somaira, Sandhu, Nicole, Moslehi, Javid, Neuman, Heather, Jemal, Ahmedin, Haddad, Tufia C., Blaes, Anne H., Villarraga, Hector R., Thompson, Carrie, Shah, Nilay D., Herrmann, Joerg
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7101030/
https://ncbi.nlm.nih.gov/pubmed/32106704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.119.005984
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars